Resource Latest COVID-19 updates All NRAS updates on COVID-19 will be included in this section. This will include updates on NRAS and what we are doing about the COVID-19 pandemic and more general updates from leading health organisations on the latest information and advice for RA patients. Print News, 21 Apr Covid-19 Outcomes in Children With JIA Severe COVID-19 Outcomes Rare Among Children and Young People With Rheumatic Diseases. According to a press release issued by the Children Arthritis and Rheumatology Research Alliance (CARRA), severe Covid-19 outcomes and hospitalisations are uncommon among children with JIA and other musculoskeletal diseases. The research used data from the following to identify children with Rheumatic and […] News, 13 Apr Thousands More Patients to Access Second Ground-Breaking Antiviral Thousands more vulnerable people eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study. Paxlovid reduced the risk of hospitalisation or death by 88% in clinical trials and is already available directly through the NHS to highest-risk patients. The UK has procured more antivirals per head than any […] News, 13 Apr The Spring Booster The spring booster vaccine is now being offered to those that are aged over 75 and those aged over 12 who are immunosuppressed. For many people that are immune suppressed this will be their 5th dose. As long as there is a 3-month gap between the date of their last vaccination, patients can now access […] Article New Covid-19 Treatment Update – Evusheld AstraZeneca’s long acting covid antibody treatment Evusheld has now been approved in the UK as of the 17th of March. This news appears to be a breakthrough in action towards protecting those who are either unable to get the vaccine or have not responded to them as well as others. Although this is a step […] Article Response to ‘Living with Covid’ On the 21st of February 2022, the government announced the lifting of all remaining covid restrictions. From the 24th of February it will no longer be a legal requirement to isolate if you test positive for covid 19. For those that are vulnerable, this has created a feeling of uncertainty and fear for the future. News, 26 Jan January 2022 announcements regarding move to Plan A On Wednesday 19th January 2022, Prime Minister Boris Johnson announced the phased relaxation of the Plan B restrictions regarding working from home, wearing masks, social distancing, and self-isolation in England. In turn, you can view the most up-to-date guidelines via the GOV.UK website which were updated following the announcement. There has been no official statement […] Article FAQs on New Antiviral Treatment Updated 20th April Changes to accessing the Antiviral treatment Previously, those that were eligible for the antiviral treatment were sent a confirmation letter and a priority PCR kit in the post. Now that PCR test are no longer in use, patients will receive a lateral flow testing kit as well as a new letter. You […] News, 23 Dec COVID-19 Update: Hope on the horizon for immuno-suppressed/compromised individuals December update on COVID-19 anti-viral medications and monoclonal antibody treatments as well as updates on 3rd primary doses and boosters. On 22nd December we hosted a panel discussion on the COVID treatments now available across the UK for those with immune mediated conditions such as RA. Watch the full video below or on our Youtube […] Article Reflections on how COVID has changed the health landscape Reflections on how COVID has changed the health landscape and highlighted the importance of supported self-management By Ailsa Bosworth, MBE As we begin 2022, I’ve taken time out to reflect on what has happened in healthcare delivery generally, but especially within rheumatology, and many of you will be aware that we have produced resources to […] News, 10 Dec Covid update: new treatment Announcement A press release has been issued relating to antiviral treatments for COVID-19. The following two announcements have been made: -There will be an antivirals trial for those testing positive with covid. This will be available to everyone over 50 and those with specific health conditions. Please refer to the link in this article to see […] News, 02 Dec The Third Vaccine Patients who are eligible Based on the Joint Committee on Vaccination and Immunisation (JCVI) recommendations, nearly all rheumatology patients (aside from those solely on hydroxychloroquine or sulfasalazine), should receive a third dose of the vaccine. Patients on a dose of Methotrexate lower than 20mg are also not eligible. Read the full independent report by the JCVI here. Who will contact Patients A letter […] News, 02 Dec Ending the Shielding Programme The decision to end shielding At the start of the COVID-19 pandemic, shielding was introduced as one of the few ways to support those who, at the time, were considered clinically extremely vulnerable (CEV). It was the right decision at the time, but we know that shielding advice is extremely restrictive and can have a significant […] News, 31 Aug The OCTAVE study results The OCTAVE study results were released on 24 August 2021 and we realise that the initial headlines could cause concern and worry. The study looked at vaccine response of those who are ‘immuno-compromised’ which includes a very wide range of people at varying levels of immune-compression. What the study has shown is that compared to people […] Article Guidance for NRAS groups on resuming in-person events Guidance on when NRAS groups may choose to resume face to face meetings (at their own risk and dependent on the profile of their members/the location/the activity) Article Information about Coronavirus (COVID-19) Commonly asked questions about government guidelines and vaccines.